Skip to content

Study conducted to see the effect of Vasadi Kwath with Erand Tail in symptoms of Vatarakta

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF VASADI KWATH AND ERAND TAIL IN VATARAKTA(GOUT).

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029039
Enrollment
33
Registered
2020-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue Health Condition 2: M109- Gout, unspecified Health Condition 3: M20-M25- Other joint disorders

Interventions

Intervention1: Vasadi Kwath(40ml) along with Erand Tail (5ml) orally Twice daily: Vasa,Aragvadha,Guduchi Each churna 5gm boiled with 160ml water reduced to 40ml. patient will be asked to sieve it and

Sponsors

Sima Balaprasad Jaju
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age limit from 20 to 70 years. Patients having clinical symptoms of Vatarakta like Pain in joints, Swelling, burning, Tenderness at joints.

Exclusion criteria

Exclusion criteria: Patient with severe form of other systemic disorders like Cardiac disease, renal failure, CVA etc will be excluded. Pregnant women and lactating mothers. Injury requiring surgical interventions.

Design outcomes

Primary

MeasureTime frame
To achieve marked relief in signs and symptoms of vataraktaTimepoint: The cure shall be assessed in 3 follow up(0,7th,15th,30th)30 days.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Sima Balaprasad Jaju

Dr D Y Patil College Of Ayurveda And Research Centre Pimpri Pune

drdgdipankar@gmail.com9822279321

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026